Brief: Guardant Health Launches Shield Multi-Cancer Detection (Mcd) Test In Multiple Markets In Asia With Manulife Partnership
16/03/2026 12:20
March 16 (Reuters) - Guardant Health Inc GH.O: GUARDANT HEALTH LAUNCHES SHIELD MULTI-CANCER DETECTION (MCD) TEST IN MULTIPLE MARKETS IN ASIA WITH MANULIFE PARTNERSHIP GUARDANT HEALTH INC - MANULIFE CUSTOMERS IN ASIA TO ACCESS SHIELD MCD TEST BEGINNING APRIL 2026 Source text: ID:nBw8JLs0ka Further company coverage: GH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte